Incomplete applications are the main cause for delays in COVID-19 vaccine authorization for children under age 5; tobacco smoking rates dropped among adults with major depression and/or substance use disorder; scientists found an association between exposure to “forever chemicals" and liver damage.
Read More
NT-proBNP Level May Influence HF Risk Among Blacks vs Whites, Men vs Women
April 27th 2022In this new subanalysis of data from the Atherosclerosis Risk in the Communities study, investigators assessed the risk of incident heart failure (HF) or death by race and sex, as influenced by N-terminal pro–B-type natriuretic peptide (NT-proBNP) concentration, prompted by growing interest in its use as a predictive biomarker for HF.
Read More
Asembia 2022 Summit to Address Biosimilar Adoption, Policy Implications for Specialty Pharmacy
April 27th 2022Numerous topics will be addressed at this year's Asembia Specialty Pharmacy Summit, held in-person in Las Vegas from May 2 through 5, including updates on cell and gene therapies and insights on the future of the industry.
Read More
Real-world Study Shows Ruxolitinib May Reduce Arterial Thrombosis in Polycythemia Vera
April 27th 2022Previous studies have shown ruxolitinib effective in symptom relief and hematocrit control for hydroxyurea-resistant polycythemia vera, but its role in disease progression is not yet clear.
Read More
Dr Michael Diaz Previews In-person Tampa IVBM Meeting
April 26th 2022Michael Diaz, MD, president and managing physician, Florida Cancer Specialists & Research Institute, previews the Tampa meeting of The American Journal of Managed Care®'s Institute for Value-Based Medicine® (IVBM), cohosted by Florida Cancer Specialists & Research Institute.
Watch
Advocating for All Patients With Chronic Kidney Disease
April 26th 2022Chronic kidney disease is the fastest-growing noncontagious disease in the United States. On this episode of Managed Care Cast, we speak with Mike Spigler, vice president of patient support and education for the American Kidney Fund, who is spearheading the Unknown Causes of Kidney Disease Project, which aims to help underserved patients get to the root cause of their kidney disease, while also helping to solve this mystery for a broader patient population.
Listen
Dr Elaine Goodman: Why Health Care Systems Should Consider the Patient Perspective
April 26th 2022When clinicians consider the patient journey from beginning to end, they begin to understand how difficult it is for patients to access care, said Elaine Goodman, MD, MBA, clinical lead for population health management, Mass General Brigham.
Watch
USPSTF Updates Preventive Aspirin Use Recommendation in CVD, CRC
April 26th 2022There may be a small, but not overwhelming, benefit for certain individuals aged 40 to 59 years who have a slightly elevated risk of future cardiovascular disease (CVD) to start taking aspirin, according to an update released by the US Preventive Services Task Force (USPSTF).
Read More
Elevated prevalence of post-traumatic stress disorder seen in family members of patients with COVID-19 treated in intensive care units; 9 rare respiratory cancers linked with burn pit exposure among veterans; adenovirus suggested as potential cause of unexplained cases of pediatric hepatitis.
Read More
High Prevalence of Metabolic Syndrome in Patients With RA Warrants Early Identification Measures
April 26th 2022A meta-analysis found that a third of patients with rheumatoid arthritis (RA) in a sample had metabolic syndrome, which can double the risk of cardiovascular outcomes in this population.
Read More
Dr Hatem Soliman Addresses the Economic Burden of Metastatic Breast Cancer Treatment
April 25th 2022The financial toxicity of newer metastatic breast cancer (MBC) treatments is a significant concern and requires stakeholders to work together to find the best value- and evidence-based treatments for patients, said Hatem Soliman, MD, medical director, Clinical Trials Office, Moffitt Cancer Center.
Watch
MoCA Scores in HD Correlate With Caudate Atrophy, Cortical Thinning, Says New Research
April 24th 2022The findings suggest that the tool can be used to not only assess cognitive impairment in Huntington disease (HD) but also to detect brain atrophy patterns associated with cognitive status in these patients.
Read More